Beyond vancomycin: Pharmacovigilance detects new drugs involved in linear IgA bullous dermatosis
Authors:
- 13 May 2025
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (1)
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and VenereologyJournal of the European Academy of Dermatology and Venereology, 2024
- Linear IgA dermatosis secondary to treatment with piperacillin-tazobactam in a nonagenarian patientAdvances in Dermatology and Allergology, 2023
- Antituberculosis Drug-induced Linear IgA DermatosisJournal of Skin and Stem Cell, 2021
- Drug‐induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 casesBritish Journal of Clinical Pharmacology, 2018